Loading clinical trials...
Loading clinical trials...
A Phase 1a/1b, Open-Label, Multicenter Study Evaluating the Safety and Feasibility of ITIL-306 in Subjects With Advanced Solid Tumors
Conditions
Interventions
ITIL-306
Locations
2
United States
Washington University School of Medicine
St Louis, Missouri, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Start Date
August 24, 2022
Primary Completion Date
October 10, 2023
Completion Date
March 6, 2026
Last Updated
April 15, 2026
NCT07227402
NCT06043817
NCT07144280
NCT06758401
NCT07431827
NCT05969860
Lead Sponsor
Instil Bio
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions